EXEL

#775
Exelixis, Inc. - Common Stock
51.4 8 USD
+0.06%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
51.21
51.72
Year Range
0.49
52.96
Daily Change
+0.06%
Monthly Change
+14.25%
6 month change
+17.59%
Year Change
+31.86%
Previous Close
51.4 5
Open
51.4 1
Low
51.2 1
High
51.7 2
Volume
246
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 12.94 B
  • Employee 1 077
  • Founded 1994
  • CEO Michael M. Morrissey
  • Website www.exelixis.com
  • Headquarter Delaware, United States
  • FIGI BBG000BQ4WF8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
14.56
Price to sales ratio
5.14

Exelixis, Inc. - Common Stock

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

News